The enhanced expression of TLRs in the periodontium with periodontitis [7,70], as well as significant contribution of TLR2 to alveolar bone loss [71–73] suggest that the inhibitory effects of GM-0111 on TLRs may provide a therapeutic benefit in periodontitis. This evidence concerns the gene TLR2 and periodontitis.